Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2026
Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosisKarlo Toljan, Brian Renner, Lynn Daboul, et al.
Neurology. Clinical Practice|July 10, 2020
Technology-enabled assessments to enhance multiple sclerosis clinical care and researchGabrielle Macaron, Brandon P Moss, Hong Li, et al.
Nature Reviews. Neurology|July 15, 2022
From the prodromal stage of multiple sclerosis to disease preventionRuth Ann Marrie, Mark Allegretta, Lisa F Barcellos, et al.
Imaging Neuroscience (Cambridge, Mass.)|October 15, 2025
Automated segmentation of multiple sclerosis lesions, paramagnetic rims, and central vein sign on MRI provides reliable diagnostic biomarkersFengling Hu, Zheng Ren, Luyun Chen, et al.
The Lancet. Neurology|September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosisFrederik Barkhof, Daniel S Reich, Jiwon Oh, et al.
Neurology|February 22, 2019
Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMSJiwon Oh, Daniel Ontaneda, Christina Azevedo, et al.
Neurology|September 2, 2025
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis ClinicBrian Renner, Elizabeth Daphne Verter, Martina Absinta, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2026
Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosisKarlo Toljan, Brian Renner, Lynn Daboul, et al.
Neurology. Clinical Practice|July 10, 2020
Technology-enabled assessments to enhance multiple sclerosis clinical care and researchGabrielle Macaron, Brandon P Moss, Hong Li, et al.
Nature Reviews. Neurology|July 15, 2022
From the prodromal stage of multiple sclerosis to disease preventionRuth Ann Marrie, Mark Allegretta, Lisa F Barcellos, et al.
Imaging Neuroscience (Cambridge, Mass.)|October 15, 2025
Automated segmentation of multiple sclerosis lesions, paramagnetic rims, and central vein sign on MRI provides reliable diagnostic biomarkersFengling Hu, Zheng Ren, Luyun Chen, et al.
The Lancet. Neurology|September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosisFrederik Barkhof, Daniel S Reich, Jiwon Oh, et al.
Neurology|February 22, 2019
Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMSJiwon Oh, Daniel Ontaneda, Christina Azevedo, et al.
Neurology|September 2, 2025
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis ClinicBrian Renner, Elizabeth Daphne Verter, Martina Absinta, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Pageof 20